| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 胶囊业务(元) | 199,787,831.52 | 366,634,844.00 | 160,840,133.33 |
| 胶原蛋白(元) | 28,839,123.10 | 55,786,349.18 | 26,190,505.01 |
| 明胶及磷酸氢钙(元) | 137,655,341.25 | 424,619,014.40 | 215,910,606.89 |
| 有机肥业务(元) | 1,952,173.19 | 3,168,664.35 | 2,407,952.37 |
| 营业成本(元) | |||
| 胶囊业务(元) | 148,914,036.36 | 292,426,322.84 | 130,641,033.07 |
| 胶原蛋白(元) | 22,412,413.47 | 41,808,165.58 | 19,457,852.81 |
| 明胶及磷酸氢钙(元) | 101,286,417.90 | 315,183,007.44 | 154,697,882.06 |
| 有机肥业务(元) | 2,151,648.65 | 2,905,639.31 | 2,272,024.78 |
| 毛利(元) | |||
| 胶囊业务(元) | 50,873,795.16 | 74,208,521.16 | 30,199,100.26 |
| 胶原蛋白(元) | 6,426,709.63 | 13,978,183.60 | 6,732,652.20 |
| 明胶及磷酸氢钙(元) | 36,368,923.35 | 109,436,006.96 | 61,212,724.83 |
| 有机肥业务(元) | -199,475.46 | 263,025.04 | 135,927.59 |
| 毛利率(%) | |||
| 胶囊业务(%) | 25.46 | 20.24 | 18.78 |
| 胶原蛋白(%) | 22.28 | 25.06 | 25.71 |
| 明胶及磷酸氢钙(%) | 26.42 | 25.77 | 28.35 |
| 有机肥业务(%) | -10.22 | 8.30 | 5.64 |
| 收入构成(%) | |||
| 胶囊业务(%) | 54.26 | 43.12 | 39.68 |
| 胶原蛋白(%) | 7.83 | 6.56 | 6.46 |
| 明胶及磷酸氢钙(%) | 37.38 | 49.94 | 53.27 |
| 有机肥业务(%) | 0.53 | 0.37 | 0.59 |
| 毛利构成(%) | |||
| 胶囊业务(%) | 54.43 | 37.50 | 30.73 |
| 胶原蛋白(%) | 6.88 | 7.06 | 6.85 |
| 明胶及磷酸氢钙(%) | 38.91 | 55.30 | 62.28 |
| 有机肥业务(%) | -0.21 | 0.13 | 0.14 |